Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
5,799,374
-
Shares change
-
+538,989
-
Total reported value, excl. options
-
$43,724,574
-
Value change
-
+$3,925,477
-
Number of buys
-
26
-
Number of sells
-
-9
-
Price
-
$7.54
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q2 2016
37 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2016.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,799,374 shares
of 48,932,355 outstanding shares and own 11.9% of the company stock.
Largest 10 shareholders include FMR LLC (2,673,385 shares), JPMORGAN CHASE & CO (1,582,231 shares), Lombard Odier Asset Management (USA) Corp (341,790 shares), BlackRock Fund Advisors (288,831 shares), VANGUARD GROUP INC (247,937 shares), Allianz Asset Management AG (119,240 shares), STATE STREET CORP (113,491 shares), MORGAN STANLEY (59,617 shares), BlackRock Institutional Trust Company, N.A. (55,543 shares), and GEODE CAPITAL MANAGEMENT, LLC (48,325 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.